SBC Medical Group Holdings (NASDAQ:SBC), a leading Management Services Organization (MSO) for a diverse range of medical franchises, today announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025.
The results highlight a year of strategic consolidation and efficiency, where the company successfully doubled its net income despite a challenging macroeconomic environment for elective medical services.
For the fourth quarter of 2025, SBC Medical reported total revenues of $40 million, an 11% decrease compared to the same period in 2024.
However, the company’s focus on high-margin franchise support and operational optimization led to a dramatic 117% year-over-year increase in net income attributable to the company, which reached $14 million. \
This resulted in earnings per share (EPS) of $0.14, a 133% jump from the prior year.
The company’s franchise network continued its steady expansion, ending the year with 283 locations—an increase of 34 clinics over the previous twelve months.
This physical growth was matched by strong brand loyalty; SBC Medical reported a 72% repeat rate for customers visiting franchisee clinics twice or more.
Total customers reached 6.6 million for the full year, a 12% increase that underscores the resilient demand for the company’s specialized medical services.
Profitability metrics remained healthy, though EBITDA reflected the impact of the lower top-line revenue.
Q4 EBITDA was $14 million, a 35% decrease year-over-year, resulting in an EBITDA margin of 34%.
Despite this compression, the company delivered a robust return on equity (ROE) of 23%, representing a 9.8 percentage point increase over 2024.